United Therapeutics | UTHR - Gross Profit On Sales


United Therapeutics reported $315.5M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Amarin USD 22.21M 28.15M Sep/2025
Ardelyx USD 106.35M 23.51M Sep/2025
Baxter International USD 577M 373M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
BioCryst Pharmaceuticals USD -88.88M 202.74M Dec/2024
Biogen USD 1.65B 34.6M Dec/2025
BioMarin Pharmaceutical USD 713.01M 81.81M Dec/2025
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Insmed USD 217.69M 106.25M Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
J&J USD 16.6B 118M Dec/2025
Lexicon Pharmaceuticals USD -16.16M 2.89M Jun/2024
Moderna USD 226M 583M Dec/2025
Omeros USD -33.16M 18.52M Jun/2024
Pfizer USD 3.54B 7.61B Sep/2025
PTC Therapeutics USD 148.38M 39.31M Dec/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sarepta Therapeutics USD 43.55M 204.36M Dec/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025
United Therapeutics USD 315.5M 286.6M Dec/2025
Vertex Pharmaceuticals USD 2.72B 62.4M Dec/2025